Literature DB >> 12222768

Role of apoptosis in the cytotoxic effect mediated by daunorubicin in cultured human retinal pigment epithelial cells.

Yu-Sheng Wang1, Yan-Nian Hui, Peter Wiedemann.   

Abstract

To investigate whether apoptosis is involved in the therapeutic effect of daunorubicin on proliferative vitreoretinopathy (PVR), cultured human retinal pigment epithelial cells (RPE) were exposed to a cytotoxic dose of 180 microg/l daunorubicin. After 12-hour treatment with the drug and 24-hour prolonged post-incubation in the drug-free medium, progressive condensation, shrinkage of cytoplasm and nucleus, and fragmented nuclei were identified by light and electron microscopy. TUNEL assay showed the characteristic apoptotic patterns of circumscribed clumps and sometimes even dark masses in nuclei. The expression of bax protein was enhanced, and the integral optical density values for immunocytochemical expression of bax protein increased by 22.0% in the drug-treated group (P < 0.05). The results demonstrated the pivotal role of apoptotic mechanism in the cytotoxic effect mediated by daunorubicin, and confirmed the relationship between the drug-induced apoptosis and overexpression of bax protein. It suggested that the upregulation of bax mediated by daunorubicin could lead to the onset of apoptosis, and therefore contribute to its therapeutic mechanisms for the treatment of PVR.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12222768     DOI: 10.1089/10807680260218542

Source DB:  PubMed          Journal:  J Ocul Pharmacol Ther        ISSN: 1080-7683            Impact factor:   2.671


  8 in total

1.  A therapeutic strategy for choroidal neovascularization based on recruitment of mesenchymal stem cells to the sites of lesions.

Authors:  Hui-Yuan Hou; Hong-Liang Liang; Yu-Sheng Wang; Zhao-Xia Zhang; Bai-Ren Wang; Yuan-Yuan Shi; Xiao Dong; Yan Cai
Journal:  Mol Ther       Date:  2010-07-20       Impact factor: 11.454

2.  Calcium overload is associated with lipofuscin formation in human retinal pigment epithelial cells fed with photoreceptor outer segments.

Authors:  L Zhang; Y-N Hui; Y-S Wang; J-X Ma; J-B Wang; L-N Ma
Journal:  Eye (Lond)       Date:  2011-02-11       Impact factor: 3.775

3.  Inhibition of migration but stimulation of proliferation of human retinal pigment epithelial cells cultured with uniform vesicles of silicone oil.

Authors:  Li-Na Ma; Yan-Nian Hui; Yu-Sheng Wang; Le Zhang; Ji-Xian Ma
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-11-27       Impact factor: 3.117

4.  Inhibition of proliferation, migration and tube formation of choroidal microvascular endothelial cells by targeting HIF-1alpha with short hairpin RNA-expressing plasmid DNA in human RPE cells in a coculture system.

Authors:  Wei Zhao; Yu-Sheng Wang; Yan-Nian Hui; Jie Zhu; Peng Zhang; Xia Li; Guo-Rui Dou
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-06-04       Impact factor: 3.117

5.  Rac1 activates HIF-1 in retinal pigment epithelium cells under hypoxia.

Authors:  Peng Zhang; Xing Zhang; Xiaofeng Hao; Yusheng Wang; Yannian Hui; Haiyan Wang; Dan Hu; Jian Zhou
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-01-23       Impact factor: 3.117

6.  Influence of Dll4 via HIF-1α-VEGF signaling on the angiogenesis of choroidal neovascularization under hypoxic conditions.

Authors:  Xiao Dong; Yu-Sheng Wang; Guo-Rui Dou; Hui-Yuan Hou; Yuan-Yuan Shi; Rui Zhang; Ke Ma; Lin Wu; Li-Bo Yao; Yan Cai; Jian Zhang
Journal:  PLoS One       Date:  2011-04-19       Impact factor: 3.240

7.  Effect of Methotrexate on an In Vitro Patient-Derived Model of Proliferative Vitreoretinopathy.

Authors:  Dhanesh Amarnani; Arturo Israel Machuca-Parra; Lindsay L Wong; Christina K Marko; James A Stefater; Tomasz P Stryjewski; Dean Eliott; Joseph F Arboleda-Velasquez; Leo A Kim
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-08-01       Impact factor: 4.799

8.  Curcumin inhibits human retinal pigment epithelial cell proliferation.

Authors:  Yun Sun; Zhi-Peng You
Journal:  Int J Mol Med       Date:  2014-07-23       Impact factor: 4.101

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.